Literature DB >> 28534285

Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.

Pinunta Nittayacharn1, Norased Nasongkla2.   

Abstract

The objective of this work was to develop self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy and studied the release profiles of doxorubicin (Dox) from different depot formulations. Tri-block copolymers of poly(ε-caprolactone), poly(D,L-lactide) and poly(ethylene glycol) named PLECs were successfully used as a biodegradable material to encapsulate Dox as the injectable local drug delivery system. Depot formation and encapsulation efficiency of these depots were evaluated. Results show that depots could be formed and encapsulate Dox with high drug loading content. For the release study, drug loading content (10, 15 and 20% w/w) and polymer concentration (25, 30, and 35% w/v) were varied. It could be observed that the burst release occurred within 1-2 days and this burst release could be reduced by physical mixing of hydroxypropyl-beta-cyclodextrin (HP-β-CD) into the depot system. The degradation at the surface and cross-section of the depots were examined by Scanning Electron Microscope (SEM). In addition, cytotoxicity of Dox-loaded depots and blank depots were tested against human liver cancer cell lines (HepG2). Dox released from depots significantly exhibited potent cytotoxic effect against HepG2 cell line compared to that of blank depots. Results from this study reveals an important insight in the development of injectable drug delivery system for liver cancer chemotherapy. Schematic diagram of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system and in vitro characterizations. (a) Dox-loaded PLEC depots could be formed with more than 90% of sustained-release Dox at 25% polymer concentration and 20% Dox-loading content. The burst release occurred within 1-2 days and could be reduced by physical mixing of hydroxypropyl-beta-cyclodextrin (HP-β-CD) into the depot system. (b) Dox released from depots significantly exhibited potent cytotoxic effect against human liver cancer cell lines (HepG2 cell line) compared to that of blank depots. (c) Dox-loaded depots showed bulk erosion with hollow core at day 60.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534285     DOI: 10.1007/s10856-017-5905-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  53 in total

1.  Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins.

Authors:  O Bekers; J H Beijnen; M Otagiri; A Bult; W J Underberg
Journal:  J Pharm Biomed Anal       Date:  1990       Impact factor: 3.935

2.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

3.  Physical stability and lyophilization of poly(epsilon-caprolactone)-b-poly(ethyleneglycol)-b-poly(epsilon-caprolactone) micelles.

Authors:  Yong Hu; Yin Ding; Yuan Li; Xiqun Jiang; Changzheng Yang; Yonghua Yang
Journal:  J Nanosci Nanotechnol       Date:  2006 Sep-Oct

4.  The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid).

Authors:  M O Omelczuk; J W McGinity
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

5.  Biocompatibility study of glycofurol in rat brains.

Authors:  Atthaporn Boongird; Norased Nasongkla; Suradej Hongeng; Nongyao Sukdawong; Waridtha Sa-Nguanruang; Noppadol Larbcharoensub
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

6.  Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model.

Authors:  Ketpat Vejjasilpa; Norased Nasongkla; Chawan Manaspon; Noppadol Larbcharoensub; Atthaporn Boongird; Suradej Hongeng; Nipan Israsena
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-16

7.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

Authors:  Norased Nasongkla; Erik Bey; Jimin Ren; Hua Ai; Chalermchai Khemtong; Jagadeesh Setti Guthi; Shook-Fong Chin; A Dean Sherry; David A Boothman; Jinming Gao
Journal:  Nano Lett       Date:  2006-11       Impact factor: 11.189

8.  L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity.

Authors:  Kyung T Oh; Eun Seong Lee; Dongin Kim; You Han Bae
Journal:  Int J Pharm       Date:  2008-03-13       Impact factor: 5.875

Review 9.  The National Cancer Institute: cancer drug discovery and development program.

Authors:  M R Grever; S A Schepartz; B A Chabner
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

10.  Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles.

Authors:  Fariyal Ahmed; Dennis E Discher
Journal:  J Control Release       Date:  2004-04-16       Impact factor: 9.776

View more
  5 in total

1.  Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation.

Authors:  Man Theerasilp; Punlop Chalermpanapun; Panya Sunintaboon; Witaya Sungkarat; Norased Nasongkla
Journal:  J Mater Sci Mater Med       Date:  2018-11-30       Impact factor: 3.896

Review 2.  Translational research in pediatric contrast-enhanced ultrasound.

Authors:  Anush Sridharan; Misun Hwang; Shelby Kutty; M Beth McCarville; Harriet J Paltiel; Maciej Piskunowicz; Sphoorti Shellikeri; Elizabeth Silvestro; George A Taylor; Ryne A Didier
Journal:  Pediatr Radiol       Date:  2021-05-15

3.  Crystallization of the Multi-Receptor Tyrosine Kinase Inhibitor Sorafenib for Controlled Long-Term Drug Delivery Following a Single Injection.

Authors:  Victoria Lai; Sarah Y Neshat; Amanda Rakoski; James Pitingolo; Johndavid Sabedra; Stephen Li; Aryaman Shodhan; Joshua C Doloff
Journal:  Cell Mol Bioeng       Date:  2021-10-18       Impact factor: 3.337

Review 4.  Supramolecular Interactions in Hybrid Polylactide Blends-The Structures, Mechanisms and Properties.

Authors:  Anna Kowalewska; Maria Nowacka
Journal:  Molecules       Date:  2020-07-23       Impact factor: 4.411

5.  Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells.

Authors:  Ei Mon Khaing; Torsak Intaraphairot; Jongjan Mahadlek; Siriporn Okonogi; Wiwat Pichayakorn; Thawatchai Phaechamud
Journal:  Gels       Date:  2022-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.